University reports research breakthrough in fatty liver disease - expects interest from big pharma
The next step is to conduct clinical studies, and a number of clinicians have already shown interest, informs the University of Copenhagen.
Age and weight increase means that too much of chemical compound ROS (reactive oxygen species) is produced, which ”stresses” the cells. The stress results in an increased risk of diabetes and the conversion of the body’s ”brown” fat to ”white” fat, which is linked to obesity and the risk of extra fat in the liver, known as fatty liver disease (FLD).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
